InterventionsHuman trial
Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes—STEP UP T2D Trial
ADA Scientific Sessions 2025 Abstract
The paper
LINGVAY I, BERGENHEIM SJ, BUSE JB et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Late-breaking 1978-LB
